Therefore, we hypothesize that in colon cancer, abnormal expression of TRPV4 disrupted the negative regulation of AKT-mTOR signaling via sustained PTEN phosphorylation during tumor development. This evidence concerns the gene AKT1 and colonic neoplasm.